Home / Actual products: Co / COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection...
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection...
- ID
- 39473011000001103
- Virtual product
- Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
- Name
- COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
- Abbreviated name
- COVID-19 Vaccine Nuvaxovid 0.5ml inj multidose vials
- Description
- COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.)
- Date of name applicability
- 23 Feb 2022
- Previous Name
- COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials
- Supplier
- Novavax CZ a.s.
- Licensed as
- Medicines - MHRA/EMA
- Previously licensed as
- None
- License change reason
- Licence Granted
- Date of change of licensing authority
- 23 Feb 2022
- EMA (European Medicines Agency) Monitoring
- 1
- Restrictions on availability
- Restricted Availability
- Licensed route
- Intramuscular